Hepatitis C Virus Infection among HIV-Infected Patients Attending Dessie Referral Hospital, Northeastern Ethiopia
Open Access
- 22 January 2021
- journal article
- research article
- Published by Hindawi Limited in International Journal of Microbiology
- Vol. 2021, 1-7
Abstract
Objective. Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) coinfection increases the incidence of end-stage liver disease which is more severe in immune-compromised HIV-infected patients than HCV infection alone. The aim of this study was to assess HCV infection and the associated risk factors among HIV/AIDS patients attending Dessie Referral Hospital, Northeastern Ethiopia. Methods. A hospital-based cross-sectional study was conducted among 249 HIV-infected adults selected by a systematic random sampling technique from January to March 2018. A structured questionnaire was used to collect sociodemographic and risk factor data. Moreover, the blood specimen was collected and tested for CD4 count and anti-HCV antibody detection according to standard operating procedures. The data obtained were entered into SPSS version 20, and descriptive statistics, bivariate and multivariate logistic regression analyses were performed. A P value <= 0.05 with a corresponding 95% confidence interval was considered as statistically significant. Result. Of a total of 249 HIV-infected study subjects, 120 (48.2%) were male and 129 (51.8%) were females, while the mean (+/- SD) age and CD4+ cells/mm3 were 39.10 (+/- 11.507) years and 316.08 + 290.607 cells/mm3, respectively. Anti-HCV antibody was detected in 13 (5.2%) patients with higher prevalence rate found in males (P = 0.078) and elders >50 years of age (P = 0.013) than their counterparts. Age group of >50 years of age (AOR = 9.070, 95% CI: 1.578, 52.117, P=0.013), longer duration of HIV treatment (AOR = 5.490, 95% CI: 1.341, 34.458, P=0.041), WHO clinical stage III/IV (AOR = 12.768, 95% CI: 2.293, 71.106, P=0.004), previous history of hospitalization (AOR = 10.234, 95% CI: 2.049, 51.118, P=0.005), tooth extraction (AOR = 6.016, 95% CI: 1.137, 36.837, P=0.048), and liver disease (AOR = 11.398, 95% CI: 1.275, 101.930, P=0.029) were statistically significant predictors of HCV infection. Conclusion. The prevalence of HCV infection is still higher and causes concern. Therefore, screening of these high-risk groups should be critical to reduce mortality and to improve clinical outcomes.Keywords
This publication has 32 references indexed in Scilit:
- HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest EthiopiaVirology Journal, 2013
- Hepatitis C virus and Human Immunodeficiency Virus coinfection among attendants of Voluntary Counseling and Testing Centre and HIV follow up clinics in Mekelle HospitalPan African Medical Journal, 2013
- Chronic HCV infection: epidemiological and clinical relevanceBMC Infectious Diseases, 2012
- Clinical variables identify seronegative HCV co-infection in HIV-infected individualsJournal of Clinical Virology, 2011
- Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern EthiopiaBMC Research Notes, 2011
- Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patientsVirology Journal, 2009
- Epidemiology of viral hepatitis and HIV co-infectionJournal of Hepatology, 2006
- Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency VirusClinical Infectious Diseases, 2003
- Higher prevalence of anti‐HCV antibodies among HIV‐positive compared to HIV‐negative inhabitants of Addis Ababa, EthiopiaJournal of Medical Virology, 2002
- Membrane‐bound, ATP‐dependent energy systems and tissue hypoxia in human gastric mucosaJournal of Gastroenterology and Hepatology, 2000